Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists

Title
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists
Authors
Keywords
-
Journal
SEMINARS IN ONCOLOGY
Volume 42, Issue 4, Pages 573-586
Publisher
Elsevier BV
Online
2015-06-06
DOI
10.1053/j.seminoncol.2015.05.008

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started